Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase

Immunology

Volumn 91, Issue 2, 1997, Pages 314-321

  Suitters, A J ^a   Shaw, S ^a   Wales, M R ^a   Porter, J R ^a   Leonard, J ^a   Woodger, R ^a   Brand, H ^a   Bodmer, M ^a   Foulkes, R ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; PRASTERONE; PRASTERONE SULFATE; STERYL SULFATASE;

ANDROGEN METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HORMONE ACTION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; INFLAMMATORY INFILTRATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030910632     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00254.x     Document Type: Article

References (35)

1. MEIKLE A.W., DAYNES R.A. & ARANEO B.A. (1991) Adrenal androgen secretion and biologic effects. Endocrinol Metab Clin North Am 20, 381.
2. PARKER L.N. (1989) Adrenal androgen metabolism. In: Adrenal Androgens in Clinical Medicine (ed. L. N. Parker), p. 3. Academic Press Inc., New York.
3. LIU C.H., LAUGHLIN G.A., FISCHER U.G. & YEN S.S.C. (1990) Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in post-menopausal women: evidence for a reduced 17,20-desmolase enzymatic activity. J Clin Endocrinol Metab 7, 900.
4. MIGEON C.J., KELLER A.R., LAWRENCE B. & SHEPARD T.H. (1957) Dehydroepiandrosterone and androsterone levels in human plasma, effect of age, sex: day-to-day and diurnal variations. J Clin Endocrinol Metab 17, 1051.
5. HOBKIRK R. (1985) Steroid sulfotransferases and steroid sulfate sulfatases: characterisation and biological roles. Can J Biochem Cell Biol 63, 1127.
6. MARKS P.A. & BANKS J.A. (1960) Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids. Proc Natl Acad Sci USA 46, 447.
7. REGELSON W., LORIA R. & KALIMI M. (1988) Hormonal intervention: 'Buffer hormones' or 'State dependency'. The role of dehydroepiandrosterone (DHEA), thyroid hormones, estrogen and hypophysectomy in aging. Ann NY Acad Sci 521, 260.
8. COLEMAN D.L., LEITER E.H. & SCHWIZER R.W. (1982) Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31, 830.
9. COLEMAN D.L. (1990) Dehydroepiandrosterone (DHEA) and diabetic syndromes in mice. In: The Biologic Role of Dehydroepiandrosterone (DHEA) (eds M. Kalimi & W. Regelson), p. 179. Walter de Gruyter and Co., Berlin.
10. CLEARY M.P. (1990). The antiobesity effect of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med 196, 8.
11. PUNJABI U., DESLYPERE J.P., VERDONCK L. & VERMEULEN A. (1983) Androgen and precursor levels in serum and testes of adult rats under basal conditions and after hCG stimulation. J Steroid Biochem 19, 1481.
12. WICHMANN U., WICHMANN G. & KRAUSE W. (1984) Serum levels of testosterone precursors, testosterone and estradiol in 10 animals. Exp Clin Endocrinol 83, 283.
13. ORENTREICH N., BRIND J.L., RIZER R.L. & VOGELMAN J.N. (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59, 551.
14. DAYNES R.A., DUDLEY D.J. & ARANEO B.A. (1990) Regulation of murine lymphokine production in vivo II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 20, 793.
15. DAYNES R.A. & ARANEO B.A. (1989) Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 19, 2319.
16. DAYNES R.A., ARANEO B.A., DOWELL T.A., HUANG K. & DUDLEY D.J. (1990) Regulation of murine lymphokine production in vivo III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 171, 979.
17. SUZUKI T., SUZUKI N., DAYNES R.A. & ENGLEMAN E.G. (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 61, 202.
18. BLAUER K.L., POTH M., ROGER W.M. & BERNTON E.W. (1991) Dehydroepiandrosterone antagonises the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129, 3174.
19. PADGETT D.A. & LORIA R.M. (1994) In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J Immunol 153, 1544.
20. MORFIN R. & COURCHAY G. (1994) Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J Steroid Biochem Molec Biol 50, 91.
21. HOWARTH N.M., PUROHIT A., REED M.J. & POTTER B.V.L. (1994) Estrone Sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J Med Chem 37, 219.
22. PUROHIT A., WILLIAMS G.J., HOWARTH N.M., POTTER N.V.L. & REED M.J. (1995) Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-sulfamate. Biochemistry 34, 11 508.
23. BRADFORD M.M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248.
24. APPEL R. & BERGER G. (1958) Uber das hydrazidosulphamid. Chem Ber 19, 1339.
25. MORTAUD S., DONSEZ-DARCEL P.L., ROUBERTOUX P.L. & DEGRELLE H. (1995) Murine steroid sulfatase (mSTS): purification, characterisation and measurement by ELISA. J Steroid Biochem Molec Biol 52, 91.
26. MEIKLE A.W., DORCHUCK R.W., ARANEO B.A. et al. (1992) The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 42, 293.
27. MCLACHLAN J.A., SERKIN C.D. & BAKOUCHE O. (1996) Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J Immunol 156, 328.
28. ROOK G.A.W., HERNANDEZ-PANDO R. & LIGHTMAN S.L. (1994) Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 15, 301.
29. SUZUKI T., SUZUKI N., ENGLEMAN E.G., MIZUSHIMA Y. & SAKANE T. (1995) Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 99, 251.
30. KALIMI M., SHAFAGOJ Y., LORIA R., PADGETT D. & REGELSON W. (1994) Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 131, 99.
31. BROWNE E.S., WRIGHT B.E., PORTER J.R. & SVEC F. (1992) Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci 303, 366.
32. ARANEO B. & DAYNES R. (1995) Dehydroepiandrosterone functions as more than an anti-glucocorticoid in preserving immunocompetence after thermal injury. Endocrinology 136, 393.
33. HENNEBOLD J.D. & DAYNES R.A. (1994) Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. Endocrinology 135, 67.
34. GREENE M.I., SCHATTEN S. & BROMBERG J.S. (1984) Delayed hypersensitivity. In: Fundamental Immunology (ed. W.E. Paul), p. 685. Raven Press, New York.
35. AUSTYN J.M. & WOOD K.J. (1993) The molecular basis of T cell responses. In: Principles of Cellular and Molecular Immunology (eds JM Austyn and KJ Wood), p. 181. Oxford University Press, New York.